Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Colon Cancer treatment details. Chemotherapy. Monash University, Melbourne, Australia

Survival: 8.0 months
Toxicity Grade: 5
Treatments: Chemotherapy
Country: Australia
City/State/Province: Melbourne
Hospital: Monash University
Journal: Link
Date: 1/2011

This study involved patients with metastatic colorectal cancer who had received prior chemotherapy. Patients were divided into two separate treatment groups. Group A consisted of 35 patients with a median age of 64 years and 21 were male. Group B had 41 patients with a median age of 63 years and 24 were male.

Group A was treated with the chemotherapy agent irinotecan. Group B was treated with irinotecan that was formulated with the drug carrier hyaluronan, called HA-irinotecan.

In group A, there were 3 treatment-related deaths reported due to neutropenic sepsis (infection), respiratory failure, and an unknown cause. Grade 3 diarrhea, nausea, and vomiting were also reported.

The maximum toxicity grade in group B was grade 4, including mucosal inflammation, neutropenia, and leucopenia. Grade 3 diarrhea, nausea, and vomiting were also reported.

The reported median overall survival was 8.0 months for group A and 10.1 months for group B.

This study was supported by Alchemia Oncology, the makers of HA-irinotecan.

Correspondence: Dr. Tracy Brown; email:

E-mail to a Friend Email Physician More Information